BioPlus Acquisition Corp. (BIOSW) Stock Analysis

What BioPlus Acquisition Corp. does

BioPlus Acquisition Corp. was established with the core objective of entering into a business combination, which may take various forms including a merger, share exchange, asset acquisition, stock purchase, or corporate reorganization, with one or more entities. The firm intends to concentrate its search for suitable partners exclusively within the life sciences industry. This company commenced operations in 2021 and is headquartered in New York, New York.

Key metrics

ETFs linked to BIOSW

Broad-market and Financial Services sector ETFs an investor holding BioPlus Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BIOSW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for BioPlus Acquisition Corp.?

BioPlus Acquisition Corp. trades under the ticker BIOSW on NASDAQ.

Which exchange is BIOSW listed on?

BIOSW is listed on NASDAQ.

What sector does BioPlus Acquisition Corp. operate in?

BioPlus Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze BIOSW in a portfolio?

PortView shows BIOSW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.